This study was the first indication that exogenous α-synuclein fibrils could act as a catalyser of intracellular α-synuclein, which in turn forms aggregates and structures that closely resemble LBs present in the brains of patients with synucleinopathies [157]. Here, SNCA is linked to synucleinopathy.